Back to results
US 8,709,413 B2Granted
Treatment of celiac disease with IgA
OwnerMichael R. Simoninventor
Life of this patent
Estimating the term…
Abstract
A process is provided for inhibiting symptoms of food allergy or food intolerance in a subject that includes the oral administration to the subject suffering from food allergy or food intolerance an IgA or an IgM. When administered in a therapeutic quantity based on the subject characteristics and the type of IgA or IgM, symptoms of food allergy or food intolerance in that subject are inhibited. Even non-secretory forms of IgA and IgM are effective when administered orally.
Claims19
A process for inhibiting symptoms of food allergy in a subject comprising:
- administering orally to the subject suffering from food allergy a purified IgA;
- and
- allowing sufficient time for said purified IgA to inhibit symptoms of food allergy in that subject wherein an allergen that induces the food allergy is present in food selected from the group consisting of:
- a milk, a peanut, a tree nut, a cauliforate, a gluten containing grain crop, a cheese, an egg, a shellfish, a fish;
- and a fruit.
2 more elements
A process for inhibiting symptoms of food intolerance in a subject comprising:
- administering orally to the subject suffering from food intolerance a purified IgA;
- and
- allowing sufficient time for said purified IgA to inhibit symptoms of food intolerance in that subject wherein a food that induces the food intolerance is present in food selected from the group consisting of:
- a milk, a peanut, a tree nut, a cauliforate, a gluten containing grain crop, a cheese, an egg, a shellfish, a fish;
- and a fruit.
2 more elements
Dependencies are inferred from the claim text.